vs
Cheer Holding, Inc.（CHR）与Cytek Biosciences, Inc.（CTKB）财务数据对比。点击上方公司名可切换其他公司
Cheer Holding, Inc.的季度营收约是Cytek Biosciences, Inc.的1.1倍（$71.0M vs $62.1M），Cheer Holding, Inc.净利率更高（10.9% vs -70.9%，领先81.9%），Cytek Biosciences, Inc.同比增速更快（8.1% vs -0.1%）
祺睿控股有限公司是一家多元化控股企业，主要在中国市场运营，核心业务板块覆盖幼儿教育服务、移动生活平台、数字内容供给及面向家庭和企业合作伙伴的整合消费解决方案。
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
CHR vs CTKB — 直观对比
营收规模更大
CHR
是对方的1.1倍
$62.1M
营收增速更快
CTKB
高出8.2%
-0.1%
净利率更高
CHR
高出81.9%
-70.9%
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $71.0M | $62.1M |
| 净利润 | $7.8M | $-44.1M |
| 毛利率 | 70.7% | 52.9% |
| 营业利润率 | 11.7% | -9.0% |
| 净利率 | 10.9% | -70.9% |
| 营收同比 | -0.1% | 8.1% |
| 净利润同比 | -37.5% | -557.1% |
| 每股收益（稀释后） | $0.67 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CHRCTKB
| Q4 25 | — | $62.1M | ||
| Q3 25 | — | $52.3M | ||
| Q2 25 | $71.0M | $45.6M | ||
| Q1 25 | — | $41.5M | ||
| Q4 24 | — | $57.5M | ||
| Q3 24 | — | $51.5M | ||
| Q2 24 | $71.1M | $46.6M | ||
| Q1 24 | — | $44.9M |
净利润CHRCTKB
| Q4 25 | — | $-44.1M | ||
| Q3 25 | — | $-5.5M | ||
| Q2 25 | $7.8M | $-5.6M | ||
| Q1 25 | — | $-11.4M | ||
| Q4 24 | — | $9.6M | ||
| Q3 24 | — | $941.0K | ||
| Q2 24 | $12.4M | $-10.4M | ||
| Q1 24 | — | $-6.2M |
毛利率CHRCTKB
| Q4 25 | — | 52.9% | ||
| Q3 25 | — | 52.7% | ||
| Q2 25 | 70.7% | 52.3% | ||
| Q1 25 | — | 48.6% | ||
| Q4 24 | — | 58.5% | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | 73.4% | 54.6% | ||
| Q1 24 | — | 51.3% |
营业利润率CHRCTKB
| Q4 25 | — | -9.0% | ||
| Q3 25 | — | -17.6% | ||
| Q2 25 | 11.7% | -23.3% | ||
| Q1 25 | — | -36.1% | ||
| Q4 24 | — | 5.2% | ||
| Q3 24 | — | -8.2% | ||
| Q2 24 | 16.4% | -18.3% | ||
| Q1 24 | — | -23.9% |
净利率CHRCTKB
| Q4 25 | — | -70.9% | ||
| Q3 25 | — | -10.5% | ||
| Q2 25 | 10.9% | -12.2% | ||
| Q1 25 | — | -27.5% | ||
| Q4 24 | — | 16.8% | ||
| Q3 24 | — | 1.8% | ||
| Q2 24 | 17.5% | -22.4% | ||
| Q1 24 | — | -13.8% |
每股收益（稀释后）CHRCTKB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $0.67 | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $1.23 | — | ||
| Q1 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $90.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $322.1M | $341.7M |
| 总资产 | $362.7M | $461.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CHRCTKB
| Q4 25 | — | $90.9M | ||
| Q3 25 | — | $93.3M | ||
| Q2 25 | — | $75.5M | ||
| Q1 25 | — | $95.3M | ||
| Q4 24 | — | $98.7M | ||
| Q3 24 | — | $162.3M | ||
| Q2 24 | $186.1M | $177.9M | ||
| Q1 24 | — | $168.8M |
股东权益CHRCTKB
| Q4 25 | — | $341.7M | ||
| Q3 25 | — | $378.6M | ||
| Q2 25 | $322.1M | $377.6M | ||
| Q1 25 | — | $379.6M | ||
| Q4 24 | — | $395.7M | ||
| Q3 24 | — | $385.5M | ||
| Q2 24 | $286.1M | $389.1M | ||
| Q1 24 | — | $392.6M |
总资产CHRCTKB
| Q4 25 | — | $461.5M | ||
| Q3 25 | — | $494.9M | ||
| Q2 25 | $362.7M | $493.3M | ||
| Q1 25 | — | $482.6M | ||
| Q4 24 | — | $499.5M | ||
| Q3 24 | — | $491.2M | ||
| Q2 24 | $333.2M | $483.7M | ||
| Q1 24 | — | $492.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.9M | $-771.0K |
| 自由现金流经营现金流 - 资本支出 | — | $-1.8M |
| 自由现金流率自由现金流/营收 | — | -2.9% |
| 资本支出强度资本支出/营收 | — | 1.6% |
| 现金转化率经营现金流/净利润 | 0.51× | — |
| 过去12个月自由现金流最近4个季度 | — | $-8.8M |
8季度趋势，按日历期对齐
经营现金流CHRCTKB
| Q4 25 | — | $-771.0K | ||
| Q3 25 | — | $-3.9M | ||
| Q2 25 | $3.9M | $108.0K | ||
| Q1 25 | — | $-125.0K | ||
| Q4 24 | — | $2.0M | ||
| Q3 24 | — | $13.2M | ||
| Q2 24 | $-6.7M | $6.2M | ||
| Q1 24 | — | $4.0M |
自由现金流CHRCTKB
| Q4 25 | — | $-1.8M | ||
| Q3 25 | — | $-4.6M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | — | $-974.0K | ||
| Q4 24 | — | $1.1M | ||
| Q3 24 | — | $12.2M | ||
| Q2 24 | — | $5.2M | ||
| Q1 24 | — | $3.4M |
自由现金流率CHRCTKB
| Q4 25 | — | -2.9% | ||
| Q3 25 | — | -8.7% | ||
| Q2 25 | — | -3.2% | ||
| Q1 25 | — | -2.3% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 23.7% | ||
| Q2 24 | — | 11.0% | ||
| Q1 24 | — | 7.6% |
资本支出强度CHRCTKB
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 1.3% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 2.0% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 2.0% | ||
| Q2 24 | — | 2.3% | ||
| Q1 24 | — | 1.3% |
现金转化率CHRCTKB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.51× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.21× | ||
| Q3 24 | — | 14.05× | ||
| Q2 24 | -0.54× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CHR
暂无分部数据
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
